India
· Delayed Price · Currency is INR SMS Pharmaceuticals Statistics
Total Valuation
NSE:SMSPHARMA has a market cap or net worth of INR 22.51 billion. The enterprise value is 25.20 billion.
| Market Cap | 22.51B |
| Enterprise Value | 25.20B |
Important Dates
The last earnings date was Tuesday, May 27, 2025.
| Earnings Date | May 27, 2025 |
| Ex-Dividend Date | Sep 23, 2024 |
Share Statistics
NSE:SMSPHARMA has 88.65 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 88.65M |
| Shares Outstanding | 88.65M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 46.96% |
| Owned by Institutions (%) | 2.43% |
| Float | 45.35M |
Valuation Ratios
The trailing PE ratio is 31.12.
| PE Ratio | 31.12 |
| Forward PE | n/a |
| PS Ratio | 2.88 |
| PB Ratio | 3.52 |
| P/TBV Ratio | 3.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 27.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.91, with an EV/FCF ratio of -60.48.
| EV / Earnings | 36.45 |
| EV / Sales | 3.22 |
| EV / EBITDA | 17.91 |
| EV / EBIT | 23.69 |
| EV / FCF | -60.48 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.49.
| Current Ratio | 1.71 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 2.24 |
| Debt / FCF | -7.46 |
| Interest Coverage | 5.64 |
Financial Efficiency
Return on equity (ROE) is 11.76% and return on invested capital (ROIC) is 7.40%.
| Return on Equity (ROE) | 11.76% |
| Return on Assets (ROA) | 5.98% |
| Return on Invested Capital (ROIC) | 7.40% |
| Return on Capital Employed (ROCE) | 12.63% |
| Revenue Per Employee | 6.54M |
| Profits Per Employee | 577,574 |
| Employee Count | 1,197 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.02 |
Taxes
In the past 12 months, NSE:SMSPHARMA has paid 249.39 million in taxes.
| Income Tax | 249.39M |
| Effective Tax Rate | 26.51% |
Stock Price Statistics
The stock price has increased by +22.03% in the last 52 weeks. The beta is 0.70, so NSE:SMSPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +22.03% |
| 50-Day Moving Average | 242.51 |
| 200-Day Moving Average | 258.30 |
| Relative Strength Index (RSI) | 51.63 |
| Average Volume (20 Days) | 120,520 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SMSPHARMA had revenue of INR 7.83 billion and earned 691.36 million in profits. Earnings per share was 8.16.
| Revenue | 7.83B |
| Gross Profit | 2.59B |
| Operating Income | 1.05B |
| Pretax Income | 940.74M |
| Net Income | 691.36M |
| EBITDA | 1.39B |
| EBIT | 1.05B |
| Earnings Per Share (EPS) | 8.16 |
Balance Sheet
The company has 415.86 million in cash and 3.11 billion in debt, giving a net cash position of -2.69 billion or -30.36 per share.
| Cash & Cash Equivalents | 415.86M |
| Total Debt | 3.11B |
| Net Cash | -2.69B |
| Net Cash Per Share | -30.36 |
| Equity (Book Value) | 6.40B |
| Book Value Per Share | 72.15 |
| Working Capital | 2.30B |
Cash Flow
In the last 12 months, operating cash flow was 817.09 million and capital expenditures -1.23 billion, giving a free cash flow of -416.71 million.
| Operating Cash Flow | 817.09M |
| Capital Expenditures | -1.23B |
| Free Cash Flow | -416.71M |
| FCF Per Share | -4.70 |
Margins
Gross margin is 33.13%, with operating and profit margins of 13.37% and 8.83%.
| Gross Margin | 33.13% |
| Operating Margin | 13.37% |
| Pretax Margin | 12.02% |
| Profit Margin | 8.83% |
| EBITDA Margin | 17.76% |
| EBIT Margin | 13.37% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.16%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 0.16% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 4.90% |
| Buyback Yield | -0.09% |
| Shareholder Yield | 0.08% |
| Earnings Yield | 3.07% |
| FCF Yield | -1.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 17, 2015. It was a forward split with a ratio of 10.
| Last Split Date | Dec 17, 2015 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |